A Single Center Randomized Open-Label Two Arm Crossover Study of Subject Productivity Improvement and Satisfaction With Migraine Treatment Using Treximet vs Usual Triptan

Trial Profile

A Single Center Randomized Open-Label Two Arm Crossover Study of Subject Productivity Improvement and Satisfaction With Migraine Treatment Using Treximet vs Usual Triptan

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Apr 2018

At a glance

  • Drugs Naproxen sodium/sumatriptan (Primary) ; Tryptamines
  • Indications Migraine
  • Focus Therapeutic Use
  • Acronyms TRXvUsualTrptn
  • Most Recent Events

    • 10 Aug 2016 Status changed from recruiting to completed.
    • 05 Feb 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
    • 23 Jun 2014 Planned primary completion date changed from 1 Jun 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top